Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement

Overview of attention for article published in Frontiers in endocrinology, January 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 9 news outlets
twitter: 4 X users

reddit: 6 Redditors
video: 1 YouTube creator

Readers on

mendeley: 177 Mendeley

So far, Altmetric has seen 10 news stories from 9 outlets.

Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone deficiency presented today at the ENDO 2022 Congress1

PharmiWeb, 14 Jun 2022

Atlanta, Georgia (US), 12 June 2022 – Today, Novo Nordisk announced results of once-weekly Sogroya® (somapacitan) injection in…

Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency

USA Life Sciences Database, 13 Jun 2022

Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone deficiency presented today at…

Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency

ValueSpectrum, 12 Jun 2022

Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone deficiency presented today at…

Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency

Biz Wire Express, 12 Jun 2022

GlobeNewswire 2022-06-12 Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 6 additional news stories.